Troglitazone suppresses cell growth of KU812 cells independently of PPAR

Author： Abe A.   Kiriyama Y.   Hirano M.   Miura T.   Kamiya H.   Harashima H.   Tokumitsu Y.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.436, Iss.1, 2002-02, pp. : 7-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin

By Gao Jian-Jun  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 574-582

Springer Publishing Company

Access to resources Recommend Favorite

Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum

By Bell D.   McDermott B.J.  

European Journal of Pharmacology, Vol. 390, Iss. 3, 2000-03 ,pp. : 237-244

Elsevier

Access to resources Recommend Favorite

Troglitazone inhibits the capacitative Ca 2+ entry in endothelial cells

By Kawasaki J.   Hirano K.   Hirano M.   Nishimura J.   Fujishima M.   Kanaide H.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 111-120

Elsevier

Access to resources Recommend Favorite

Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1

By  

Current Pharmaceutical Design, Vol. 19, Iss. 35, 2013-10 ,pp. : 6382-6389

Bentham Science Publishers

Access to resources Recommend Favorite

Red Blood Cells as Modulators of T Cell Growth and Survival

By  

Current Pharmaceutical Design, Vol. 10, Iss. 2, 2004-01 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite